Samsung Bioepis to Present Post-hoc Analysis of Phase 3
Post-hoc analysis of Phase 3 study to highlight transfusion avoidance results of SB12 compared to reference eculizumab-treated groups INCHEON, Korea, May ...
Source: globenewswire.com
Transfusion Avoidance News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Transfusion Avoidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.